GUILLERMO GARCIA-MANERO to Drug Evaluation, Preclinical
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Drug Evaluation, Preclinical.
Connection Strength
0.188
-
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leuk Res. 2010 Feb; 34(2):221-8.
Score: 0.077
-
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor. Blood. 2006 Aug 15; 108(4):1174-82.
Score: 0.061
-
Preclinical activity of FF-10501-01, a novel inosine-5'-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia. Leuk Res. 2017 08; 59:85-92.
Score: 0.033
-
Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies. Cancer. 2008 Jun; 112(11):2341-51.
Score: 0.018